BIRC5 and breast carcinoma: In contrast, it is highly expressed in most human cancers 7, 8 and its expression is associated with tumour progression and poor clinical outcome.8, 9, 10 Moriai et al11 recently showed that targeting survivin may overcome tamoxifen resistance in breast cancer cells.